Some of the prominent players identified in the global market for hemoglobin A1c testing devices, based on the number of products, include Bio-Rad Laboratories, Inc., Tosoh Corporation, Siemens Healthcare, F. Hoffmann-La Roche Ltd, Alere, Inc., Chek Diagnostics, Danaher Corporation, and Trinity Biotech plc. These prominent players dominate the market for hemoglobin A1c testing devices with their exclusive products.
For example, Bio-Rad Laboratories, Inc., offers devices based on ion-exchange HPLC and boronate affinity chromatography. Its ‘in2in’ point-of-care device is the latest addition with the automated boronate affinity chromatography technique. Additionally, Tososh Corporation offers many HbA1c testing devices based on ion-exchange HPLC technology whereas Siemens Healthcare presents two leading HbA1c testing products with immunoassay technology. According to a report by Transparency Market Research, the global hemoglobin A1c testing market is expected to reach US$1.8 bn by 2019.
POC HbA1c Testing Devices Market Projected for Robust Growth
The global hemoglobin A1c testing devices market is segmented on the basis of end use and technology. Based on end use, this study includes laboratory and point-of-care (POC) testing devices. Laboratory testing devices continue to be the leading segment in the global market by end use and is projected to reach a valuation of US$1.1 bn by 2019. The POC HbA1c testing devices market, on the other hand, is expected to grow at a higher CAGR during the forecast period owing to the rising demand for these devices in developing economies such as India, Brazil, Africa, and others where access to laboratory testing is limited.
Geographically, North America holds the dominant share in the global market for hemoglobin A1c testing devices, owing to high patient awareness levels about HbA1c testing. This market share is, however, is expected to decline by 2019 with Asia Pacific gaining much traction by the end of the forecast period. The report notes that the market in the emerging economies of the Middle East, Africa, and Latin America is driven by factors such as the presence of high unmet healthcare needs, the high prevalence of diabetes, and increasing awareness about the various HbA1c testing technologies.
Exponentially Rising Cases of Diabetics Driving Demand
As per the International Diabetes Federation (IDF), the number of diabetics in the world is projected to reach 642 million by 2040, rising from 415 million in 2015. The report identifies this significant chunk of population as the primary driver in the market for hemoglobin A1c testing devices. Western Pacific and Southeast Asia are projected to have the most number of diabetics by 2035. Moreover, rising geriatric population is another factor that is driving the demand for hemoglobin A1c testing devices. People aged over 55 commonly suffer from diabetes and other endocrine diseases. Furthermore, the diabetes control and complications trial (DCCT) and United Kingdom prospective diabetes study (UKPDS) researches have established the fact that hemoglobin A1c testing on a regular basis improves the health outcome of a diabetes patient. This proven benefit is expected to encourage the market for the same during the forecast period. Conversely, the presence of viable and cost-efficient conventional blood glucose testing is hindering the awareness and concurrent adoption of hemoglobin A1c testing devices, globally.
According to the author of the report, “Emerging economies such as India, China, Philippines, Brazil, and other high growth countries in Asia Pacific, Africa, and the Middle East offer several untapped opportunities. These countries are investing heavily on improving their healthcare infrastructure. Also, the rapid commercialization of devices for diagnosis of diabetes is further fueling the market.”
The information presented in this review is based on a Transparency Market Research report, titled, “Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019.”
Key Segments of the Hemoglobin A1c Testing Devices Market
Hemoglobin A1cTesting Devices Market, by End-use
- Laboratory Testing Devices
- Point-of-Care (POC)Testing Devices
Hemoglobin A1cTesting Devices Market, by Technology
- Ion-Exchange High Performance Liquid Chromatography (HPLC)
- Boronate Affinity Chromatography
- Direct Enzymatic Assay
- Others (Micro-Optical Detection Method and Capillary Electrophoresis)
Hemoglobin A1cTesting Devices Market, by Geography
- North America
- Rest of the World (RoW)
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our Report to take the right decision.View Report